Results 131 to 140 of about 103,351 (342)
A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's Disease
Abstract Background Parkinson's disease (PD) is a complex multifactorial disorder with a genetic component in about 15% of cases. Multiplications and point mutations in SNCA gene, encoding α‐synuclein (aSyn), are linked to rare familial forms of PD. Objective Our goal was to assess the clinical presentation and the biological effects of a novel K58N ...
Mohammed Al‐Azzani +24 more
wiley +1 more source
POTILASOPAS BOTULIINITOKSIINIHOITOON TULEVALLE LAPSELLE [PDF]
Opinnäytetyön tarkoituksena oli tehdä potilasopas botuliinitoksiinihoitoon tulevalle lapselle. Potilasopasta käytetään valmistaessa lasta tulevaan toimenpiteeseen sekä hoitoa antavassa yksikössä että kotona.
Koskinen, Saija, Virnes, Kirsi
core
RRP12 Variants Are Associated With Autosomal Recessive Brain Calcifications
Abstract Background Primary brain calcifications are observed in several inherited diseases due to different pathogenic mechanisms, including the disruption of the neurovascular unit, mitochondrial dysfunction, and impaired nucleic acid metabolism.
Edoardo Monfrini +19 more
wiley +1 more source
The role of the host—Neutrophil biology
Abstract Neutrophilic polymorphonuclear leukocytes (neutrophils) are myeloid cells packed with lysosomal granules (hence also called granulocytes) that contain a formidable antimicrobial arsenal. They are terminally differentiated cells that play a critical role in acute and chronic inflammation, as well as in the resolution of inflammation and wound ...
Iain L. C. Chapple +4 more
wiley +1 more source
Cosmetic use of botulinum toxin type A in the elderly
Christine M ChengDepartment of Clinical Pharmacy, University of California, San Francisco, CA, USAAbstract: Botulinum toxin type A injections are one of the most popular cosmetic procedures for diminishing the appearance of facial lines caused by ...
Christine M Cheng
doaj
From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction
Since its regulatory approval over a half-century ago, botulinum toxin has evolved from one of the most potent neurotoxins known to becoming routinely adopted in clinical practice.
Lucas Rempel +5 more
doaj +1 more source
EPI Update, July 20, 2007 [PDF]
Weekly newsletter for Center For Acute Disease Epidemiology of Iowa Department of Public ...
core
Interstitial Cystitis/Bladder Pain Syndrome in Men
ABSTRACT Aims In April 2025, the Wake Forest Institute for Regenerative Medicine hosted a Global Consensus meeting on interstitial cystitis/bladder pain syndrome (IC/BPS) in Winston‐Salem, NC. The goal of this meeting was to establish attainable targets in phenotyping, diagnosis, and biomarkers for IC/BPS.
Madeline Snipes +5 more
wiley +1 more source
Botulinum Toxin and Its Contribution to the Treatment of Masseteric Hypertrophy
With discovery and use of botulinum toxin masseteric hypertrophy has become treatable in a minimal invasive way. The authors discuss the masseteric hypertrophy as such as well as they describe a technique of clinical application of botulinum toxin in its
R. Jurkovič, P. Macák
doaj

